These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32546843)
1. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843 [TBL] [Abstract][Full Text] [Related]
2. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk. Liu J; Prager-van der Smissen WJ; Schmidt MK; Collée JM; Cornelissen S; Lamping R; Nieuwlaat A; Foekens JA; Hooning MJ; Verhoef S; van den Ouweland AM; Hogervorst FB; Martens JW; Hollestelle A Sci Rep; 2016 Jul; 6():30026. PubMed ID: 27424772 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes. Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA; Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936 [TBL] [Abstract][Full Text] [Related]
4. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers. Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998 [TBL] [Abstract][Full Text] [Related]
5. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674 [TBL] [Abstract][Full Text] [Related]
6. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer. Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738 [TBL] [Abstract][Full Text] [Related]
7. Association between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis. Zhang J; Xiao L; Qin Z; Xu A; Zhao K; Liang C; Miao C; Zhu J; Chen W; Hua Y; Liu Y; Zhang C; Yu Y; Su S; Wang Z Oncotarget; 2016 Oct; 7(41):67101-67110. PubMed ID: 27626483 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of homeobox protein B13 (HOXB13) gene G84E mutation in patients with prostate cancer. Bıyıkoğlu M; Tanrıverdi R; Bozlu M; Şenel S; Fidancı ŞB; Tamer L; Akbay E World J Urol; 2024 Aug; 42(1):476. PubMed ID: 39115757 [TBL] [Abstract][Full Text] [Related]
10. A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men. Lin X; Qu L; Chen Z; Xu C; Ye D; Shao Q; Wang X; Qi J; Chen Z; Zhou F; Wang M; Wang Z; He D; Wu D; Gao X; Yuan J; Wang G; Xu Y; Wang G; Dong P; Jiao Y; Yang J; Ou-Yang J; Jiang H; Zhu Y; Ren S; Zhang Z; Yin C; Wu Q; Zheng Y; Turner AR; Tao S; Na R; Ding Q; Lu D; Shi R; Sun J; Liu F; Zheng SL; Mo Z; Sun Y; Xu J Prostate; 2013 Jan; 73(2):169-75. PubMed ID: 22718278 [TBL] [Abstract][Full Text] [Related]
11. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men. Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563 [TBL] [Abstract][Full Text] [Related]
12. Homeobox B13 G84E Mutation and Prostate Cancer Risk. Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799 [TBL] [Abstract][Full Text] [Related]
13. The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer. Akbari MR; Kluźniak W; Rodin R; Li S; Wokołorczyk D; Royer R; Kashyap A; Menkiszak J; Lubinski J; Narod SA; Cybulski C Breast Cancer Res Treat; 2012 Dec; 136(3):907-9. PubMed ID: 23099437 [TBL] [Abstract][Full Text] [Related]
14. Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls. Shang Z; Zhu S; Zhang H; Li L; Niu Y Eur Urol; 2013 Jul; 64(1):173-6. PubMed ID: 23518396 [No Abstract] [Full Text] [Related]
15. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Xu J; Lange EM; Lu L; Zheng SL; Wang Z; Thibodeau SN; Cannon-Albright LA; Teerlink CC; Camp NJ; Johnson AM; Zuhlke KA; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Maier C; Luedeke M; Vogel W; Schleutker J; Wahlfors T; Tammela T; Schaid D; McDonnell SK; DeRycke MS; Cancel-Tassin G; Cussenot O; Wiklund F; Grönberg H; Eeles R; Easton D; Kote-Jarai Z; Whittemore AS; Hsieh CL; Giles GG; Hopper JL; Severi G; Catalona WJ; Mandal D; Ledet E; Foulkes WD; Hamel N; Mahle L; Moller P; Powell I; Bailey-Wilson JE; Carpten JD; Seminara D; Cooney KA; Isaacs WB; Hum Genet; 2013 Jan; 132(1):5-14. PubMed ID: 23064873 [TBL] [Abstract][Full Text] [Related]
16. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients. Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944 [TBL] [Abstract][Full Text] [Related]
17. Association between germline HOXB13 G84E mutation and risk of prostate cancer. Akbari MR; Trachtenberg J; Lee J; Tam S; Bristow R; Loblaw A; Narod SA; Nam RK J Natl Cancer Inst; 2012 Aug; 104(16):1260-2. PubMed ID: 22781434 [TBL] [Abstract][Full Text] [Related]